# Effect of Dietary Glycemic Index on Beta-cell Function

> **NCT01386645** · NA · COMPLETED · sponsor: **Seattle Institute for Biomedical and Clinical Research** · enrollment: 56 (actual)

## Conditions studied

- Impaired Glucose Tolerance
- Oxidative Stress
- Prediabetes
- Impaired Fasting Glucose

## Interventions

- **OTHER:** low glycemic index (LGI) diet
- **OTHER:** high glycemic index (HGI) diet plus placebo (PLAC)
- **DRUG:** high glycemic index diet plus N-acetylcysteine

## Key facts

- **NCT ID:** NCT01386645
- **Lead sponsor:** Seattle Institute for Biomedical and Clinical Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386645, "Effect of Dietary Glycemic Index on Beta-cell Function". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01386645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*